Literature DB >> 22859244

The use of cyclosporine in dermatology.

Luis Dehesa1, Adriana Abuchar, Almudena Nuno-Gonzalez, Magalys Vitiello, Francisco A Kerdel.   

Abstract

Cyclosporine is an immunosuppressive drug that acts selectively on T-cells by inhibiting calcineurin phosphorylase. It has been used in dermatology since its approval for US Food and Drug Administration in 1997 for the use in psoriasis. While indicated only for the treatment of moderate to severe psoriasis, cyclosporine has also been used as an off-label drug for the treatment of various inflammatory skin conditions, including atopic dermatitis, blistering disorders, and connective tissue diseases. In this article, we review the use of cyclosporine in dermatology.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22859244

Source DB:  PubMed          Journal:  J Drugs Dermatol        ISSN： 1545-9616            Impact factor:   2.114


  7 in total

1.  Pharmacokinetic interaction study of ticagrelor and cyclosporine in healthy volunteers.

Authors:  Renli Teng; Mirjana Kujacic; Judith Hsia
Journal:  Clin Drug Investig       Date:  2014-08       Impact factor: 2.859

2.  In vitro Characterization and Release Studies of Combined Nonionic Surfactant-Based Vesicles for the Prolonged Delivery of an Immunosuppressant Model Drug.

Authors:  Akhtar Rasul; Muhammad Imran Khan; Mujeeb Ur Rehman; Ghulam Abbas; Nosheen Aslam; Shabbir Ahmad; Khizar Abbas; Pervaiz Akhtar Shah; Muhammad Iqbal; Ali Mohammad Ahmed Al Subari; Talal Shaheer; Shahid Shah
Journal:  Int J Nanomedicine       Date:  2020-10-14

3.  Successful Treatment of Hydroxychloroquine-Induced Recalcitrant Acute Generalized Exanthematous Pustulosis with Cyclosporine: Case Report and Literature Review.

Authors:  Başak Yalçın; Seray Çakmak; Betül Yıldırım
Journal:  Ann Dermatol       Date:  2015-07-29       Impact factor: 1.444

4.  Comparison of Efficacy and Safety of Ciclosporin to Prednisolone in the Treatment of Erythema Nodosum Leprosum: Two Randomised, Double Blind, Controlled Pilot Studies in Ethiopia.

Authors:  Saba M Lambert; Shimelis D Nigusse; Digafe T Alembo; Stephen L Walker; Peter G Nicholls; Munir H Idriss; Lawrence K Yamuah; Diana N J Lockwood
Journal:  PLoS Negl Trop Dis       Date:  2016-02-26

5.  Potential Mechanism of Action of Cyclosporin A in Human Dermal Fibroblasts-Transcriptomic Analysis of CYPs.

Authors:  Grażyna Janikowska; Alina Pyka-Pająk; Tomasz Janikowski; Jolanta Adamska; Urszula Mazurek; Przemysław Jędrusik
Journal:  Molecules       Date:  2018-07-05       Impact factor: 4.411

6.  Variances in the mRNA expression profile of TGF-β1-3 isoforms and its TGF-βRI-III receptors during cyclosporin a treatment of psoriatic patients.

Authors:  Anna Michalska-Bańkowska; Dominika Wcisło-Dziadecka; Beniamin Grabarek; Ligia Brzezińska-Wcisło; Urszula Mazurek; Natalia Salwowska; Mirosław Bańkowski
Journal:  Postepy Dermatol Alergol       Date:  2018-07-19       Impact factor: 1.837

7.  [Appropriate off-label prescription in practice].

Authors:  M Augustin
Journal:  Hautarzt       Date:  2013-10       Impact factor: 0.751
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.